Skip to main content
. 2022 Nov 24;14(12):2594. doi: 10.3390/pharmaceutics14122594

Figure 5.

Figure 5

Relative cell viabilities of A549 cells and HT1080 cells exposed to MCP50 and MSP50 at various concentrations (A); cytotoxicity of A549 cells (B), and HT1080 cells (C) exposed to free doxorubicin (DOX) and DOX-loaded MCP50 (MCP-D) and DOX-loaded MSP50 (MSP-D) micelles at various DOX concentrations.